Medicine
Clenpiq 12 g/3.5 g/10 mg per 175 mL oral liquid
Clenpiq 12 g/3.5 g/10 mg per 175 mL oral liquid is a prescription medicine containing Anhydrous citric acid, Magnesium oxide and Sodium picosulfate for oral use, marketed by Ferring Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not refrigerate or freeze. Store CLENPIQ at 25°C (77°F). Excursions…
Key facts
- Active ingredient (INN)
- Anhydrous citric acid, Magnesium oxide and Sodium picosulfate
- Brand
- Clenpiq
- Strength
- 12 g/3.5 g/10 mg per 175 mL
- Dosage form
- Oral liquid
- Route
- Oral
- Packs
- 2 bottles
- Marketing authorisation holder
- Ferring Pharmaceuticals
- Manufacturer
- Ferring Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Do not refrigerate or freeze. Store CLENPIQ at 25°C (77°F). Excursions permitted at 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 29 March 2023
- Identifiers
- RxCUI 2626364, 2626366DailyMed set ID e95fff66-4ec0-4001-a727-33e66a5ec7d5NDC 55566-6800Application NDA209589
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 2 bottle in 1 carton / 175 mL in 1 bottle | 55566-6800-1 | Ferring Pharmaceuticals | 29 March 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Anhydrous citric acid, Magnesium oxide and Sodium picosulfate is a fixed-dose combination of a calculi dissolution agent, an anti-coagulant and an osmotic laxative. It is available as oral liquid. MedsAcross supplies Anhydrous citric acid, Magnesium oxide and Sodium picosulfate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Anhydrous citric acid, Magnesium oxide and Sodium picosulfateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- CLENPIQ prescribing information (Ferring Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Clenpiq 12 g/3.5 g/10 mg per 175 mL oral liquid for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.